Literature DB >> 24165451

Safety assessment of myogenic stem cell transplantation and resulting tumor formation.

Stephanie A Jacobs1, Felicia L Lane, Quynh-Anh Pham, Gabriel Nistor, Rockelle Robles, Camille Chua, Bryan Boubion, Kathryn Osann, Hans Keirstead.   

Abstract

OBJECTIVES: To assess for stem cell migration to liver and lung after transplantation in injured rat anal sphincters. To evaluate histological findings of unanticipated ectopic foci of growth.
METHODS: This is a prospective study involving 33 female virginal Sprague-Dawley rats. Anal sphincters were transected and repaired under sterile technique. Animals received injections of 5.0 × 10 myogenic stem cells (24 rats) or sham control (9 rats) and were killed on day 30. Liver and lung samples were obtained. Upon encountering abnormal foci of growth, further staining protocols were employed. Enzyme-linked immunosorbent assay studies evaluated stem cell media for in vitro growth factor secretion.
RESULTS: No evidence of cell migration to liver or lung was found at the time of euthanasia in any study animal. Ectopic foci of growth were noted in 2 transplant rats. Further histological evaluations of these growths were consistent with benign tumors: no nuclear abnormalities and no evidence of proliferation at day 30. Enzyme-linked immunosorbent assay studies demonstrated positive secretion of vascular endothelial growth factor and insulin growth factor into the media of cultured rat myogenic stem cells.
CONCLUSIONS: Whereas distant migration was not encountered in the liver or lung, 2 transplanted rats developed abnormal foci of growth, that is, tumors, from the external anal sphincter-raising further safety questions. Additional evaluation of these foci seemed benign. Possible explanations include cell trapping, stem cell overgrowth, and/or paracrine factors. The lack of cell migration supports that future investigation of safety parameters could focus locally.

Entities:  

Mesh:

Year:  2013        PMID: 24165451     DOI: 10.1097/SPV.0000000000000035

Source DB:  PubMed          Journal:  Female Pelvic Med Reconstr Surg        ISSN: 2151-8378            Impact factor:   2.091


  5 in total

Review 1.  Regenerative medicine provides alternative strategies for the treatment of anal incontinence.

Authors:  Søren Gräs; Cæcilie Krogsgaard Tolstrup; Gunnar Lose
Journal:  Int Urogynecol J       Date:  2016-06-16       Impact factor: 2.894

2.  The Effect of Mesenchymal Stem Cells, Adipose Tissue Derived Stem Cells, and Cellular Stromal Vascular Fraction on the Repair of Acute Anal Sphincter Injury in Rats.

Authors:  Wenbin Chen; Zijian He; Shuyu Li; Zixin Wu; Jin Tan; Weifeng Yang; Guanwei Li; Xiaoting Pan; Yuying Liu; Feng-Juan Lyu; Wanglin Li
Journal:  Bioengineering (Basel)       Date:  2022-07-15

3.  Rat model of anal sphincter injury and two approaches for stem cell administration.

Authors:  Jacobo Trébol; Tihomir Georgiev-Hristov; Luz Vega-Clemente; Ignacio García-Gómez; Ana Carabias-Orgaz; Mariano García-Arranz; Damián García-Olmo
Journal:  World J Stem Cells       Date:  2018-01-26       Impact factor: 5.326

4.  Functional Outcome of Human Adipose Stem Cell Injections in Rat Anal Sphincter Acute Injury Model.

Authors:  Kirsi Kuismanen; Miia Juntunen; Nathaniel Narra Girish; Heikki Tuominen; Heini Huhtala; Kari Nieminen; Jari Hyttinen; Susanna Miettinen
Journal:  Stem Cells Transl Med       Date:  2018-01-31       Impact factor: 6.940

Review 5.  Stem cell therapy for faecal incontinence: Current state and future perspectives.

Authors:  Jacobo Trébol; Ana Carabias-Orgaz; Mariano García-Arranz; Damián García-Olmo
Journal:  World J Stem Cells       Date:  2018-07-26       Impact factor: 5.326

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.